1. Justiz Vaillant AA, Goyal A, Bansal P, et al. Systemic lupus erythematosus [online book]. 2020. https://www.ncbi.nlm.nih.gov/books/NBK535405/#article-24526.s2. Accessed 11 Aug 2021.
2. Ronnblom L, Leonard D. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med. 2019;6(1):e000270.
3. AstraZeneca. Saphnelo (anifrolumab-fnia): US prescribing information. 2021. https://www.accessdata.fda.gov/. Accessed 11 Aug 2021.
4. AstraZeneca. Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus [media release]. 2 Aug 2021. https://www.astrazeneca.com.
5. MedImmune Inc. MedImmune and Medarex announce collaboration to develop and commercialize fully human antibodies for autoimmune diseases [media release]. 23 Nov 2004. http://www.medimmune.com.